Teacher Retirement System of Texas Has $1.02 Million Stock Holdings in LivaNova PLC (NASDAQ:LIVN)

Teacher Retirement System of Texas decreased its stake in LivaNova PLC (NASDAQ:LIVN) by 36.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 22,019 shares of the company’s stock after selling 12,772 shares during the quarter. Teacher Retirement System of Texas’ holdings in LivaNova were worth $1,020,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Nordea Investment Management AB boosted its holdings in shares of LivaNova by 22.2% in the fourth quarter. Nordea Investment Management AB now owns 68,711 shares of the company’s stock worth $3,188,000 after buying an additional 12,470 shares during the period. Harbor Capital Advisors Inc. acquired a new position in LivaNova in the 4th quarter worth approximately $1,954,000. KBC Group NV boosted its stake in LivaNova by 130.5% in the 4th quarter. KBC Group NV now owns 99,928 shares of the company’s stock worth $4,628,000 after purchasing an additional 56,580 shares during the period. Rhumbline Advisers raised its stake in LivaNova by 0.5% during the 4th quarter. Rhumbline Advisers now owns 177,938 shares of the company’s stock valued at $8,240,000 after purchasing an additional 899 shares during the period. Finally, PNC Financial Services Group Inc. lifted its holdings in shares of LivaNova by 29.1% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,311 shares of the company’s stock valued at $292,000 after purchasing an additional 1,424 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

LivaNova Price Performance

NASDAQ LIVN opened at $39.13 on Friday. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $2.13 billion, a PE ratio of 93.17 and a beta of 1.10. LivaNova PLC has a 12-month low of $36.85 and a 12-month high of $64.48. The company has a 50 day moving average price of $44.51 and a two-hundred day moving average price of $48.48.

Wall Street Analysts Forecast Growth

LIVN has been the topic of a number of research analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $64.00 price target on shares of LivaNova in a report on Monday, March 17th. The Goldman Sachs Group dropped their target price on LivaNova from $64.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Mizuho decreased their price target on shares of LivaNova from $70.00 to $60.00 and set an “outperform” rating for the company in a report on Wednesday, February 26th. StockNews.com upgraded shares of LivaNova from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, March 25th. Finally, Wolfe Research lowered shares of LivaNova from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating, five have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $61.17.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.